BUY Infosys — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))6 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Sensex, Nifty open higher; HCL Tech, Tech Mahindra, Infosys, RIL shares lead gains
NewsGoogle News·6 Aug · today
3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·6 Aug · today
Infosys Expands Metsä Group AI Partnership; Shares Rise 0.56%
NewsGoogle News·5 Aug · yesterday
Infosys Finacle deploys wealth management platform at HDFC Bank, replacing legacy systems
NewsGoogle News·4 Aug · 2d ago
Infosys shares rise 2.06%, trading at Rs 1,153.40
NewsGoogle News·3 Aug · 3d ago
IT Stocks F&O Check: Wipro Calls Surge, TCS Faces 2,500 Hurdle; What Infosys Options Signal
NewsGoogle News·6 Aug · today
Infosys Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·23 Jul · 2w ago
Infosys shares fall 2% in today's trade; stock among top losers on Nifty 50
NewsGoogle News·4 Aug · 2d ago
TCS, Infosys, HCLTech Fall As Traders Cut F&O Positions In IT Stocks Ahead Of Expiry
NewsGoogle News·4 Aug · 2d ago
TCS, Infosys, HCLTech fall up to 4%: Why IT stocks are under pressure today
NewsGoogle News·31 Jul · 6d ago
Infosys shares declines nearly 3 per cent after revised FY27 guidance
NewsGoogle News·24 Jul · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Infosys
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · Same day · target ₹1,175 · Expired
- BUY — Rakesh Bansal22 Oct 2026 · ~2 weeks · target ₹1,200 · SL hit
- BUY — Rakesh Bansal21 Oct 2026 · ~2 weeks · target ₹1,222 · Active
- BUY — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹1,100 · Target hit
- SELL — Kunal Bothra13 Oct 2026 · ~2 weeks · target ₹1,000 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

